Literature DB >> 15131129

Lysine beta311 of protein geranylgeranyltransferase type I partially replaces magnesium.

Heather L Hartman1, Katherine E Bowers, Carol A Fierke.   

Abstract

Protein geranylgeranyltransferase type I (GGTase I) catalyzes the attachment of a geranylgeranyl lipid group near the carboxyl terminus of protein substrates. Unlike protein farnesyltransferase (FTase) and protein geranylgeranyltransferase type II, which require both Zn(II) and Mg(II) for maximal turnover, GGTase I turnover is dependent only on Zn(II). In FTase, the magnesium ion is coordinated by aspartate beta352 and the diphosphate of farnesyl diphosphate to stabilize the developing charge in the transition state (Pickett, J. S., Bowers, K. E., and Fierke, C. A. (2003) J. Biol. Chem. 278, 51243-51250). In GGTase I, lysine beta311 is substituted for this aspartate and is proposed to replace the catalytic function of Mg(II) (Taylor, J. S., Reid, T. S., Terry, K. L., Casey, P. J., and Beese, L. S. (2003) EMBO J. 22, 5963-5974). Here we demonstrate that the prenylation rate constant catalyzed by wild type GGTase I (k(chem) = 0.18 +/- 0.02 s(-1)) is not dependent on Mg(II), is approximately 20-fold slower than the maximal rate constant catalyzed by FTase, and has a single pKa of 6.4 +/- 0.1, likely reflecting deprotonation of the peptide thiol. Mutation of lysine beta311 in GGTase I to alanine (Kbeta311A) or aspartate (Kbeta311D) decreases the k(chem) in the absence of magnesium 9-41-fold without significantly affecting the binding affinity of either substrate. Furthermore, the geranylgeranylation rate constant is enhanced by the addition of Mg(II) for Kbeta311A and Kbeta311D GGTase I 2-5-fold compared with wild type GGTase I with K(Mg) of 140 +/- 10 mm and 6.4 +/- 0.8 mm, respectively. These results demonstrate that lysine beta311 of GGTase I partially replaces the catalytic function of Mg(II) observed in FTase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15131129     DOI: 10.1074/jbc.M403469200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

Review 1.  Unraveling the mechanism of the farnesyltransferase enzyme.

Authors:  Sérgio Filipe Sousa; Pedro Alexandrino Fernandes; Maria João Ramos
Journal:  J Biol Inorg Chem       Date:  2004-12-21       Impact factor: 3.358

2.  Molecular dynamics analysis of a series of 22 potential farnesyltransferase substrates containing a CaaX-motif.

Authors:  Sérgio F Sousa; João T S Coimbra; Diogo Paramos; Rita Pinto; Rodrigo S Guimarães; Vitor Teixeira; Pedro A Fernandes; Maria J Ramos
Journal:  J Mol Model       Date:  2012-09-26       Impact factor: 1.810

3.  Insights into the mechanistic dichotomy of the protein farnesyltransferase peptide substrates CVIM and CVLS.

Authors:  Yue Yang; Bing Wang; Melek N Ucisik; Guanglei Cui; Carol A Fierke; Kenneth M Merz
Journal:  J Am Chem Soc       Date:  2012-01-06       Impact factor: 15.419

4.  Simultaneous Site-Specific Dual Protein Labeling Using Protein Prenyltransferases.

Authors:  Yi Zhang; Melanie J Blanden; Ch Sudheer; Soumyashree A Gangopadhyay; Mohammad Rashidian; James L Hougland; Mark D Distefano
Journal:  Bioconjug Chem       Date:  2015-12-04       Impact factor: 4.774

5.  Structure of protein geranylgeranyltransferase-I from the human pathogen Candida albicans complexed with a lipid substrate.

Authors:  Michael A Hast; Lorena S Beese
Journal:  J Biol Chem       Date:  2008-08-19       Impact factor: 5.157

Review 6.  Protein prenylation: enzymes, therapeutics, and biotechnology applications.

Authors:  Charuta C Palsuledesai; Mark D Distefano
Journal:  ACS Chem Biol       Date:  2014-12-08       Impact factor: 5.100

Review 7.  Temperature-Responsive Nano-Biomaterials from Genetically Encoded Farnesylated Disordered Proteins.

Authors:  Md Shahadat Hossain; Zhe Zhang; Sudhat Ashok; Ashley R Jenks; Christopher J Lynch; James L Hougland; Davoud Mozhdehi
Journal:  ACS Appl Bio Mater       Date:  2022-01-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.